产品名称 | NebuSelect™ Recombinant Human SEZ6L2, His-tag |
---|---|
目录号 | NBL-242124 |
别名 | SEZ6L2; BSRP-A; PSK-1; SEZ6L2; UNQ1903/PRO4349 |
外观 | see COA |
分子量 | Leu28-Asn844 |
CAS | N/A |
溶解度 | Water Soluble |
存储条件 | Short term 4℃; Long term -20℃. |
保存时间 | 2 years |
备注1 | Q6UXD5-1 |
备注2 |
目录号 | 规格 | 价格 | 库存状态 | |
NBL-242124-100ug | 100ug | Inquire | Inquire | |
NBL-242124-1mg | 1mg | Inquire | Inquire | |
NBL-242124-Customized Size | N/A | Inquire | Inquire |
Product Name:
NebuSelect™ Recombinant Human SEZ6L2, His-tag
Catalog#:
NBL-242124
Description:
NebuSelect™ Recombinant Human SEZ6L2, His-tag(Cat#NBL-242124) is expressed in HEK293 with His tag at the C-Terminus.It contains Leu28-Asn844.
Species:
Human
Expression System:
HEK293
Molecular Weight:
The protein has a predicted MW of 88.5 kDa. Due to glycosylation, the protein migrates to 120-140 kDa based on Bis-Tris PAGE result.
Target Name:
SEZ6L2; BSRP-A; PSK-1; SEZ6L2; UNQ1903/PRO4349
Target Information:
Seizure-related 6 homolog (mouse)-like 2 (SEZ6L2) was shown to be involved in transcription of a type 1 transmembrane protein for regulating cell fate. SEZ6L2 was significantly up-regulated in tumour tissues of patients with CRC compared with adjacent normal tissues. Up-regulation of SEZ6L2 was correlated with a poor prognosis in patients with CRC. Furthermore, SEZ6L2 expression was inversely correlated with the expression of cytochrome C in malignant tissues in patients with CRC.
Amino Acid Sequence:
Leu28-Asn844
Purity:
>95%
Formulation:
see COA
Endotoxin:
<1EU/ug(LAL Method)
Storage:
4°C for short term.
-20°C for long term.
To get more information, please contact us freely.